Skip to main content

Advertisement

Log in

Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis

  • Original Article
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

For esophageal squamous cell carcinoma (ESCC) invading the muscularis mucosa (T1a-MM) or upper submucosa (T1b-SM1, up to 200 µm), the curative effectiveness of endoscopic submucosal dissection (ESD) and additional therapeutic strategies remain controversial. The present study aims to investigate the effectiveness of ESD followed by different therapeutic strategies in treating such patients.

Methods

A total of 242 patients with T1a-MM/T1b-SM1 ESCCs were involved. Data on therapeutic outcomes and long-term survivals were collected for analysis. Propensity score-matched analysis was performed to compensate for selection bias between patients with no additional therapy (NAT group) and those with additional therapy (AT group).

Results

R0 resection rate was 83.1% and curative resection rate was 78.5%. After a mean follow-up period of 57.8 ± 27.3 months, the cumulative recurrence rate was 7.9%. The 5-year overall survival (OS) and cause-specific survival (CSS) rate was 91.1% and 94.0%. In a matched cohort of 24 pairs, the 5-year OS and CSS rates showed no significant difference between NAT group (82.0% and 87.1%) and AT group (86.0% and 89.9%) (P > 0.05). In the subgroup of patients with noncurative ESD (n = 52), the 5-year OS and CSS rates were significantly higher in surgery group (90.2% and 95.2%) than that in NAT group (50.1% and 59.5%) and chemoradiotherapy group (51.4% and 60.0%) (P < 0.05).

Conclusions

ESD with no additional therapy could achieve favorable long-term outcomes in treating T1a-MM/T1b-SM1 ESCCs. For patients with noncurative ESD, surgery ranks a prime recommendation over CRT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013) Oesophageal carcinoma. Lancet 381:400–412

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30

    Article  PubMed  Google Scholar 

  3. Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, Omori T, Sugiura H, Goda K, Kaise M, Inoue H, Ishikawa H, Ochiai A, Shimoda T, Watanabe H, Tajiri H, Saito D (2010) Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 28:1566–1572

    Article  PubMed  PubMed Central  Google Scholar 

  4. Min YW, Lee H, Song BG, Min BH, Kim HK, Choi YS, Lee JH, Hwang NY, Carriere KC, Rhee PL, Kim JJ, Zo JI, Shim YM (2018) Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis. Gastrointest Endosc 88:624–633

    Article  PubMed  Google Scholar 

  5. Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, Kagaya H, Shimizu Y, Hokari K, Tsukagoshi H, Shinomura Y, Fujita M (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72:255–264

    Article  PubMed  Google Scholar 

  6. Ishihara R, Arima M, Iizuka T, Oyama T, Katada C, Kato M, Goda K, Goto O, Tanaka K, Yano T, Yoshinaga S, Muto M, Kawakubo H, Fujishiro M, Yoshida M, Fujimoto K, Tajiri H, Inoue H, Japan Gastroenterological Endoscopy Society Guidelines Committee of ESD/EMR for Esophageal Cancer (2020) Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 32:452–493

    Article  PubMed  Google Scholar 

  7. Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Repici A, Vieth M, De Ceglie A, Amato A, Berr F, Bhandari P, Bialek A, Conio M, Haringsma J, Langner C, Meisner S, Messmann H, Morino M, Neuhaus H, Piessevaux H, Rugge M, Saunders BP, Robaszkiewicz M, Seewald S, Kashin S, Dumonceau JM, Hassan C, Deprez PH (2015) Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 47:829–854

    Article  PubMed  Google Scholar 

  8. NCCN 2021 Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers. http://www.nccn.org. Version4.2021. Updated August 3

  9. Yao J, Li J, Wang P, Liu F, Li Z (2018) A novel technique using high energy synchronous double-wave laser in endoscopic submucosal dissection of patients with superficial esophageal neoplasm. Endoscopy 50:1175–1179

    Article  PubMed  Google Scholar 

  10. Tamiya Y, Nakahara K, Kominato K, Serikawa O, Watanabe Y, Tateishi H, Takedatsu H, Toyonaga A, Sata M (2010) Pneumomediastinum is a frequent but minor complication during esophageal endoscopic submucosal dissection. Endoscopy 42:8–14

    Article  CAS  PubMed  Google Scholar 

  11. Zhou G, Yuan F, Cai J, Tang X, Gong W, Su L, Zhang Y (2017) Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Thorac Cancer 8:489–494

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Qi ZP, Chen T, Li B, Ren Z, Yao LQ, Shi Q, Cai SL, Zhong YS, Zhou PH (2018) Endoscopic submucosal dissection for early esophageal cancer in elderly patients with relative indications for endoscopic treatment. Endoscopy 50:839–845

    Article  PubMed  Google Scholar 

  13. Ikeda A, Hoshi N, Yoshizaki T, Fujishima Y, Ishida T, Morita Y, Ejima Y, Toyonaga T, Kakechi Y, Yokosaki H, Azuma T (2015) Endoscopic Submucosal Dissection (ESD) with additional therapy for superficial esophageal cancer with submucosal invasion. Intern Med 54:2803–2813

    Article  PubMed  Google Scholar 

  14. Muto M, Minashi K, Nihei K (2016) Efficacy of combined endoscopic resection and chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma (ESCC): a single-arm confirmatory study (JCOG0508). J Clin Oncol 34:4013

    Article  Google Scholar 

  15. Hamada K, Ishihara R, Yamasaki Y, Hanaoka N, Yamamoto S, Arao M, Suzuki S, Iwatsubo T, Kato M, Tonai Y, Shichijo S, Matsuura N, Nakahira H, Kanesaka T, Akasaka T, Takeuchi Y, Higashino K, Uedo N, Iishi H, Kanayama N, Hirata T, Kawaguchi Y, Konishi K (2017) Teshima T (2017) Efficacy and Safety of Endoscopic Resection Followed by Chemoradiotherapy for Superficial Esophageal Squamous Cell Carcinoma: A Retrospective Study. Clin Transl Gastroenterol 8:e110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kudou M, Shiozaki A, Fujiwara H, Konishi H, Shoda K, Arita T, Kosuga T, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Kubota T, Nakanishi M, Okamoto K, Dohi O, Konishi H, Naito Y, Otsuji E (2017) Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer. Anticancer Res 37:5301–5307

    PubMed  Google Scholar 

  17. Kawaguchi G, Sasamoto R, Abe E, Ohta A, Sato H, Tanaka K, Maruyama K, Kaizu M, Ayukawa F, Yamana N, Liu J, Takeuchi M, Kobayashi M, Aoyama H (2015) The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. Radiat Oncol 10:31

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hisano O, Nonoshita T, Hirata H, Sasaki T, Watanabe H, Wakiyama H, Ono M, Ohga S, Honda H (2018) Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control. Radiat Oncol 13:14

    Article  PubMed  PubMed Central  Google Scholar 

  19. Liu Y, Qian D, Tang B, Fan C, Yu J, Lin H, Bai J, Zhao X (2020) Feasibility of endoscopic submucosal dissection for early esophageal squamous cell carcinoma with relative indications. Dig Surg 38:14–23

    Article  CAS  PubMed  Google Scholar 

  20. Naito S, Yoshio T, Ishiyama A, Tsuchida T, Tokura J, Namikawa K, Tokai Y, Yoshimizu S, Horiuchi Y, Hirasawa T, Asari T, Mine S, Watanabe M, Ogura M, Chin K, Fukuzawa M, Itoi T, Fujisaki J (2021) Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Dig Endosc. https://doi.org/10.1111/den.14154

    Article  PubMed  Google Scholar 

  21. Kato K, Ito Y, Nozaki I, Daiko H, Kojima T, Yano M, Ueno M, Nakagawa S, Takagi M, Tsunoda S, Abe T, Nakamura T, Okada M, Toh Y, Shibuya Y, Yamamoto S, Katayama H, Nakamura K, Kitagawa Y, Japan Esophageal Oncology Group of the Japan Clinical Oncology Group (2021) Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma. Gastroenterology 161:1878–1886

    Article  CAS  PubMed  Google Scholar 

  22. Sun F, Yuan P, Chen T, Hu J (2014) Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: a systematic review and meta-analysis. J Cardiothorac Surg 9:78

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Choi JY, Park YS, Jung HY, Ahn JY, Kim MY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Cho KJ, Kim JH (2011) Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Gastrointest Endosc 73(881–889):889.e1–2

    Google Scholar 

  24. Li B, Chen H, Xiang J, Zhang Y, Kong Y, Garfield DH, Li H (2013) Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma. Thorac Cardiovasc Surg 146:1198–1203

    Article  Google Scholar 

  25. Takahashi K, Hashimoto S, Mizuno KI, Kobayashi T, Tominaga K, Sato H, Kohisa J, Ikarashi S, Hayashi K, Takeuchi M, Yokoyama J, Kawai H, Sato Y, Kobayashi M, Terai S (2018) Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma. Endoscopy 50:662–670

    Article  PubMed  Google Scholar 

  26. Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ (2015) Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg 99:1879–1885

    Article  PubMed  Google Scholar 

  27. Jo YY, Yu J, Song KJ, Jang JY, Yoo YJ, Kim SB, Park SR, Kim YH, Kim HR, Kim JH (2021) Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: a retrospective study. Radiother Oncol 162:112–118

    Article  CAS  PubMed  Google Scholar 

  28. Haneda R, Booka E, Ishii K, Kikuchi H, Hiramatsu Y, Kamiya K, Ogawa H, Yasui H, Takeuchi H, Tsubosa Y (2021) Evaluation of definitive chemoradiotherapy versus radical esophagectomy in clinical T1bN0M0 esophageal squamous cell carcinoma. World J Surg 45:1835–1844

    Article  PubMed  Google Scholar 

  29. Minashi K, Nihei K, Mizusawa J, Takizawa K, Yano T, Ezoe Y, Tsuchida T, Ono H, Iizuka T, Hanaoka N, Oda I, Morita Y, Tajika M, Fujiwara J, Yamamoto Y, Katada C, Hori S, Doyama H, Oyama T, Nebiki H, Amagai K, Kubota Y, Nishimura K, Kobayashi N, Suzuki T, Hirasawa K, Takeuchi T, Fukuda H, Muto M (2019) Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology 157:382-390.e3

    Article  PubMed  Google Scholar 

  30. Koterazawa Y, Nakamura T, Oshikiri T, Kanaji S, Tanaka S, Ishida T, Yamashita K, Matsuda T, Morita Y, Suzuki S, Kakeji Y (2018) A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma. Surg Today 48:783–789

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Tsou YK, Lee CH, Le PH, Chen BH (2020) Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? a critical review. Crit Rev Oncol Hematol 147:102883

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the National Nature Science Foundation of China (No. 82000622), the Shanghai Municipal Health Commission Scientific Research Project General Program (No. 201940082), and the Shanghai Health Commission Promotion Project for Advanced and Proper Technology (No. 2019SY050).

Author information

Authors and Affiliations

Authors

Contributions

FL: Study conception and design; JL: acquisition, analysis and interpretation of data; JL: drafting of the manuscript; FL: critical revision of the manuscript for important intellectual content; LW, XS, JC, ZJ, DZ: technical or material support; FL, ZL: study supervision. The article has been approved by all authors to be published.

Corresponding authors

Correspondence to Zhaoshen Li or Feng Liu.

Ethics declarations

Disclosures

Drs. Jun Li, Luowei Wang, Xinggang Shi, Jie Chen, Zhendong Jin, Duowu Zou, Zhaoshen Li and Feng Liu stated that they do not have any conflict of interests or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 25 KB)

464_2022_9683_MOESM2_ESM.tif

Supplementary file2 (TIF 1692 KB) Supplementary Figure 1. Patients flow from the initiation of ESD to death or the last follow-up

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Wang, L., Shi, X. et al. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis. Surg Endosc 37, 1761–1770 (2023). https://doi.org/10.1007/s00464-022-09683-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-022-09683-z

Keywords

Navigation